Statin users saw a 12 percent reduction in the odds of colorectal cancer, according to the study’s results.
The study was conducted by researchers at the University of Michigan at Ann Arbor and included more than 2.5 million participants from 22 scientific studies.
“Observational studies have suggested that long-term use of statins is associated with reduced risk of several cancers, including breast, prostate, lung, pancreas and liver,” said Jewel Samadder, MD, MSc, in the news release. “Our findings suggest that randomized controlled trials designed to test the hypothesis that statins reduce the risk of colorectal cancer are warranted.”
Read the ACG news release about statins (pdf).
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
